AIDS Clinical Trials Group Annual Meeting [PDF]

11 studies completed accrual. – ACTG A5264 (Treatment of early KS). – ACTG A5288 (MULTI-OCTAVE [3rd-line ART in RLS]

27 downloads 20 Views 37KB Size

Recommend Stories


AIDS Clinical Trials Group 5197: A Placebo
Don't fear change. The surprise is the only way to new discoveries. Be playful! Gordana Biernat

Clinical Trials
Live as if you were to die tomorrow. Learn as if you were to live forever. Mahatma Gandhi

Clinical Trials
Don't count the days, make the days count. Muhammad Ali

clinical trials
This being human is a guest house. Every morning is a new arrival. A joy, a depression, a meanness,

Clinical Trials
You often feel tired, not because you've done too much, but because you've done too little of what sparks

Clinical Trials
When you talk, you are only repeating what you already know. But if you listen, you may learn something

Clinical Trials
This being human is a guest house. Every morning is a new arrival. A joy, a depression, a meanness,

Clinical trials
You're not going to master the rest of your life in one day. Just relax. Master the day. Than just keep

Clinical Trials
Be like the sun for grace and mercy. Be like the night to cover others' faults. Be like running water

Mid Essex Clinical Commissioning Group Board Meeting
Kindness, like a boomerang, always returns. Unknown

Idea Transcript


State of the ACTG June, 2016 Daniel R. Kuritzkes, MD Principal Investigator and Chair AIDS Clinical Trials Group

Progress on ACTG Trials 

10 studies opened to accrual – – – – – – – – – –

ACTG A5300 (PHOENIx feasibility study) ACTG A5324 (InMIND) ACTG A5329 (IFN-free treatment of HCV) ACTG A5337 (Sirolimus) ACTG A5338 (PK of rifampicin with DMPA and EFV) ACTG A5340 (ATI after VRC01) ACTG A5346 (Sitagliptin) ACTG A5348 (LDV/SOF for HCV Retreatment) ACTG A5350 (Effect of Visibiome on inflammation) ACTG A5353 (DTG + 3TC dual therapy)

Progress on ACTG Trials 

11 studies completed accrual – – – – – – – – – – –

ACTG A5264 (Treatment of early KS) ACTG A5288 (MULTI-OCTAVE [3rd-line ART in RLS]) ACTG A5290 (Rifabutin and LPV/r) ACTG A5297 (PIs and malaria) ACTG A5300 (PHOENIx feasibility study) ACTG A5307 (Essentiality of INH) ACTG A5316 (PK of ART and vaginal ring contraceptive) ACTG A5317 (Methotrexate) ACTG A5325 (Isotretinoin) ACTG A5340 (ATI after VRC01) ACTG A5342 (VRC01 and the reservoir)

Progress on ACTG Trials 

9 studies completed follow-up – – – – – – – – –

ACTG A5274 (REMEMBER) ACTG A5297 (PIs and malaria) ACTG A5298 (HPV vaccine) ACTG A5305 (HPTN 069; MVC for PrEP) ACTG A5307 (Essentiality of INH) ACTG A5314 (Telmisartan) ACTG A5317 (Methotrexate) ACTG A5326 (anti-PD-L1 Ab) ACTG A5340 (ATI after VRC01)

ACTG Accrual (June, 2015– May, 2016) 2116 enrolled into interventional trials 1326 enrolled into A5300 (over 6 months!) 445 enrolled into other observational studies 926 enrolled into A5128 or A5243 4813 participants enrolled across all studies 2544 participants enrolled at international sites 2108 participants enrolled at US sites 161 participants enrolled at non-ACTG CRSs

ACTG Abstracts and Publications  

51 abstracts presented at 11 meetings 61 manuscripts published or in press – – – – – – – –

AIDS Res Hum Retrovir 3 AIDS 9 Ann Intern Med 2 Clin Infect Dis 10 JAIDS 8 J Infect Dis 6 Lancet 1 Nat Med 1

(AIDS Behav, Antimicrob Agents Chemother, J Neurovirol, J Virol, Lancet HIV, OFID, Stat Med)

Smile Life

When life gives you a hundred reasons to cry, show life that you have a thousand reasons to smile

Get in touch

© Copyright 2015 - 2024 PDFFOX.COM - All rights reserved.